Navigation Links
Gene expression findings a step toward better classification and treatment of juvenile arthritis
Date:6/29/2009

Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). Eventually such findings could enable doctors to target more aggressive treatment to children at risk of more severe arthritis, while those likely to have milder disease could be spared the stronger treatments that carry a greater risk of side effects. The researchers were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health.

JIA is an inflammatory and sometimes disabling joint disease that affects an estimated 294,000 children in the United States. At present, making a diagnosis of JIA is imprecise and based largely on the presence of joint inflammation persisting for at least six weeks, for which no other cause can be determined, says Robert A. Colbert, M.D., Ph.D., chief of the NIAMS Pediatric Translational Research Branch. Based on the number of joints involved and other clinical features (fever and rash, for example), doctors classify patients into one of four or five major subtypes of JIA, which helps them predict a patient's most likely outcome and guide appropriate treatments. "But, recent research suggests there is more variability in JIA than the four or five major subtypes we currently recognize," Dr. Colbert says.

In the first of two such NIAMS-supported studies to be published in the July issue of Arthritis & Rheumatism, scientists led by Michael Barnes, Ph.D., of Cincinnati Children's Hospital Medical Center used a large data set to compare a number of children newly diagnosed with one of four major subtypes of JIA persistent oligoarthritis (affecting four or fewer joints), polyarthritis (affecting five or more joints), systemic arthritis (with fever and rash and inflammation throughout the body) and enthesitis-related arthritis (affecting the junctions between tendons and bo
'/>"/>

Contact: Trish Reynolds
reynoldsp2@mail.nih.gov
301-496-8190
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Omega fatty acid balance can alter immunity and gene expression
2. GEN highlights increasing use of digital gene expression profiling
3. Facial expressions of emotion are innate, not learned, says new study
4. Krumlauf Lab demonstrates modulation of gene expression by protein coding regions
5. Exercise helps overweight children reduce anger expression
6. Social interactions can alter gene expression in the brain, and vice versa
7. Conaway Lab identifies novel mechanism for regulation of gene expression
8. Predicting acute GVHD by gene expression could improve liver stem cell transplant outcomes
9. Scientists discover small RNAs that regulate gene expression and protect the genome
10. Gene-environment interaction in yeast gene expression
11. Powerful integration of lipid metabolic profiling with gene expression analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... recent Yokahama IPCC meeting painted a stark warning on ... which has a greenhouse effect 32 times that of ... shown that humic substances act as fully regenerable electron ... are held in wetlands instead of being released to ... system is disrupted it may enter into a vicious ...
(Date:4/17/2014)... the University of Texas Medical Branch at Galveston ... treated with radiation for cervical cancer should begin ... , The UTMB researchers, finding a high incidence ... treated with radiation, offer new recommendations that the ... screening about eight years after their initial cervical ...
(Date:4/17/2014)... "The Modern View of Domestication," a special feature of ... of Sciences ( PNAS ) published April 29, ... in our deep history that most of us take ... Age, people in many spots around the globe shifted ... cultivating livestock and plants. , It seems so straightforward ...
Breaking Biology News(10 mins):Methane climate change risk suggested by proof of redox cycling of humic substances 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4
... new edition of a major textbook will be simultaneously ... approach to publishing that permits the textbook to reach ... , the largest and most authoritative text in its ... through collaboration between the Consortium of Glycobiology Editors, Cold ...
... Solar warming pales versus human influence ... climate, but their relative roles and regional impacts ... studies point to increasing human-generated greenhouse gas and ... surface warming after 1967, while some empirical analyses ...
... that once sang with the croaks, chirps and ribbits ... victims of a fungus that,s decimating amphibian populations worldwide. ... than a decade, but until recently scientists knew little ... ecosystem. A University of Georgia study that is the ...
Cached Biology News:Novel publishing approach puts textbook in more hands 2Novel publishing approach puts textbook in more hands 3Novel publishing approach puts textbook in more hands 4AGU journal highlights -- Oct. 16, 2008 2AGU journal highlights -- Oct. 16, 2008 3AGU journal highlights -- Oct. 16, 2008 4AGU journal highlights -- Oct. 16, 2008 5AGU journal highlights -- Oct. 16, 2008 6AGU journal highlights -- Oct. 16, 2008 7UGA study reveals ecosystem-level consequences of frog extinctions 2UGA study reveals ecosystem-level consequences of frog extinctions 3
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, has ... an emerging biomedical company acquiring, developing, manufacturing, and marketing ... Free report download: http://equitiesiq.com/reports/alliqua/ , In late ... and Board, which launched the company’s new strategy to ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... DIEGO, Aug. 5 Arena Pharmaceuticals, Inc.,(Nasdaq: ... second quarter,ended June 30, 2008., Total revenues ... million,compared to $4.8 million in the second quarter ... Arena,s contract manufacturing agreement with,Siegfried Ltd and $0.6 ...
... IRIDEX,Corporation (Nasdaq: IRIX ) today announced that it ... market closes on Tuesday, August,12, 2008. In conjunction with ... the investment community at 5:00 p.m. Eastern Time on,Tuesday, ... quarter and other,business developments., Interested parties may access ...
... Inc.,(Nasdaq: NGSX ), a biopharmaceutical company focused on ... will,report results for its second quarter 2008 on Wednesday, ... call to review the results will begin at 4:30 ... will be hosted by Anthony DiTonno,President and Chief Executive ...
Cached Biology Technology:Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 2Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 3Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 4Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 5Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 6Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 7Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 8Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 9NeurogesX to Report Second Quarter 2008 Financial Results 2NeurogesX to Report Second Quarter 2008 Financial Results 3
Immunogen: Synthetic peptide based on the sequence: SPSSGPSLTADSMWR Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Endoglin/CD105 Fluorescein MAb (Clone 209701)...
... is an inhibitor of ... concentration of inhibitor required ... must be determined empirically ... micromolar inhibitor is sufficient ...
...
Biology Products: